Related Experiment Video
Updated: Jul 19, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.4K
Mild cognitive impairment in multiple system atrophy: a brain network disorder.
1Institute of Clinical Neurobiology, Alberichgasse 5/13, 1150, Vienna, Austria. kurt.jellinger@univie.ac.at.
Journal of Neural Transmission (Vienna, Austria : 1996)
|August 15, 2023
Summary
Cognitive impairment is common in multiple system atrophy (MSA). Research suggests structural and functional brain changes, particularly in subcortical limbic and cerebello-cerebral networks, may underlie this decline.
Area of Science:
- Neuroscience
- Neurology
- Neurodegenerative Disorders
Background:
- Cognitive impairment (CI) is increasingly recognized in multiple system atrophy (MSA), a neurodegenerative disorder.
- Mild cognitive impairment (MCI) affects up to 44% of MSA patients, impacting executive functions, attention, visuospatial, and verbal abilities.
- The pathophysiological mechanisms of CI in MSA remain controversial despite evolving understanding.
Purpose of the Study:
- To review current understanding of cognitive impairment in multiple system atrophy.
- To explore potential structural and functional brain changes associated with MCI in MSA.
- To highlight the need for further research into MSA's cognitive decline.
Main Methods:
- Review of recent neuroimaging studies (morphometric and functional analyses).
- Analysis of findings related to gray matter volume and functional connectivity.
- Discussion of neuropathological findings in moderate to severe CI and limitations in MCI stage.
Main Results:
- Neuroimaging studies show conflicting results regarding gray matter atrophy.
- Functional analyses indicate reduced connectivity in specific brain regions (parietal lobe, cuneus, precuneus, limbic structures, cerebello-cerebral circuit).
- Structural and functional changes in subcortical limbic structures and cerebello-cerebral networks may link to early cognitive decline in MSA.
Conclusions:
- Early cognitive decline in MSA may involve subcortical limbic structures and disrupted cerebello-cerebral networks.
- Moderate to severe CI in MSA often involves co-pathologies like Alzheimer's and Lewy body disease.
- Further neuroimaging and neuropathological studies are crucial for understanding MCI in MSA, developing biomarkers, and enabling early diagnosis and treatment.
Related Concept Videos
Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K

